nodes	percent_of_prediction	percent_of_DWPC	metapath
Phentolamine—SIGMAR1—Donepezil—Alzheimer's disease	0.772	1	CbGbCtD
Phentolamine—Peptic ulcer—Rivastigmine—Alzheimer's disease	0.00431	0.034	CcSEcCtD
Phentolamine—Abdominal pain upper—Galantamine—Alzheimer's disease	0.00277	0.0219	CcSEcCtD
Phentolamine—Orthostatic hypotension—Galantamine—Alzheimer's disease	0.00277	0.0219	CcSEcCtD
Phentolamine—Abdominal pain upper—Donepezil—Alzheimer's disease	0.00215	0.017	CcSEcCtD
Phentolamine—Orthostatic hypotension—Donepezil—Alzheimer's disease	0.00215	0.017	CcSEcCtD
Phentolamine—Bradycardia—Galantamine—Alzheimer's disease	0.00214	0.0169	CcSEcCtD
Phentolamine—NISCH—telencephalon—Alzheimer's disease	0.00206	0.079	CbGeAlD
Phentolamine—Angina pectoris—Donepezil—Alzheimer's disease	0.00198	0.0156	CcSEcCtD
Phentolamine—Orthostatic hypotension—Memantine—Alzheimer's disease	0.00195	0.0154	CcSEcCtD
Phentolamine—Cardiac disorder—Galantamine—Alzheimer's disease	0.00195	0.0154	CcSEcCtD
Phentolamine—Flushing—Galantamine—Alzheimer's disease	0.00195	0.0154	CcSEcCtD
Phentolamine—Abdominal pain upper—Rivastigmine—Alzheimer's disease	0.00191	0.0151	CcSEcCtD
Phentolamine—Orthostatic hypotension—Rivastigmine—Alzheimer's disease	0.00191	0.0151	CcSEcCtD
Phentolamine—Angiopathy—Galantamine—Alzheimer's disease	0.00191	0.015	CcSEcCtD
Phentolamine—Arrhythmia—Galantamine—Alzheimer's disease	0.00188	0.0148	CcSEcCtD
Phentolamine—ADRA1D—forebrain—Alzheimer's disease	0.00187	0.0717	CbGeAlD
Phentolamine—Angina pectoris—Memantine—Alzheimer's disease	0.0018	0.0142	CcSEcCtD
Phentolamine—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.00179	0.0141	CcSEcCtD
Phentolamine—Myocardial infarction—Donepezil—Alzheimer's disease	0.00178	0.014	CcSEcCtD
Phentolamine—Angina pectoris—Rivastigmine—Alzheimer's disease	0.00176	0.0139	CcSEcCtD
Phentolamine—ADRA1D—telencephalon—Alzheimer's disease	0.00172	0.0659	CbGeAlD
Phentolamine—Bradycardia—Donepezil—Alzheimer's disease	0.00166	0.0131	CcSEcCtD
Phentolamine—Acute coronary syndrome—Memantine—Alzheimer's disease	0.00162	0.0128	CcSEcCtD
Phentolamine—Myocardial infarction—Memantine—Alzheimer's disease	0.00161	0.0127	CcSEcCtD
Phentolamine—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.00159	0.0125	CcSEcCtD
Phentolamine—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.00158	0.0125	CcSEcCtD
Phentolamine—Hypertension—Galantamine—Alzheimer's disease	0.00158	0.0125	CcSEcCtD
Phentolamine—Chest pain—Galantamine—Alzheimer's disease	0.00156	0.0123	CcSEcCtD
Phentolamine—Bradycardia—Memantine—Alzheimer's disease	0.00151	0.0119	CcSEcCtD
Phentolamine—Bradycardia—Rivastigmine—Alzheimer's disease	0.00147	0.0116	CcSEcCtD
Phentolamine—Nervous system disorder—Galantamine—Alzheimer's disease	0.00146	0.0116	CcSEcCtD
Phentolamine—Tachycardia—Galantamine—Alzheimer's disease	0.00146	0.0115	CcSEcCtD
Phentolamine—Arrhythmia—Donepezil—Alzheimer's disease	0.00145	0.0115	CcSEcCtD
Phentolamine—Hypotension—Galantamine—Alzheimer's disease	0.00139	0.011	CcSEcCtD
Phentolamine—Cardiac disorder—Memantine—Alzheimer's disease	0.00137	0.0108	CcSEcCtD
Phentolamine—Flushing—Memantine—Alzheimer's disease	0.00137	0.0108	CcSEcCtD
Phentolamine—Flushing—Rivastigmine—Alzheimer's disease	0.00134	0.0106	CcSEcCtD
Phentolamine—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.00134	0.0106	CcSEcCtD
Phentolamine—Angiopathy—Memantine—Alzheimer's disease	0.00134	0.0106	CcSEcCtD
Phentolamine—Paraesthesia—Galantamine—Alzheimer's disease	0.00134	0.0106	CcSEcCtD
Phentolamine—Mediastinal disorder—Memantine—Alzheimer's disease	0.00133	0.0105	CcSEcCtD
Phentolamine—Arrhythmia—Memantine—Alzheimer's disease	0.00132	0.0104	CcSEcCtD
Phentolamine—Angiopathy—Rivastigmine—Alzheimer's disease	0.00131	0.0104	CcSEcCtD
Phentolamine—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.0013	0.0103	CcSEcCtD
Phentolamine—Arrhythmia—Rivastigmine—Alzheimer's disease	0.00129	0.0102	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00129	0.0102	CcSEcCtD
Phentolamine—Hypertension—Donepezil—Alzheimer's disease	0.00122	0.00966	CcSEcCtD
Phentolamine—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00122	0.00964	CcSEcCtD
Phentolamine—Chest pain—Donepezil—Alzheimer's disease	0.00121	0.00953	CcSEcCtD
Phentolamine—SIGMAR1—telencephalon—Alzheimer's disease	0.0012	0.0459	CbGeAlD
Phentolamine—Abdominal pain—Galantamine—Alzheimer's disease	0.00118	0.00932	CcSEcCtD
Phentolamine—NISCH—cerebellum—Alzheimer's disease	0.00114	0.0439	CbGeAlD
Phentolamine—Nervous system disorder—Donepezil—Alzheimer's disease	0.00113	0.00896	CcSEcCtD
Phentolamine—Hypertension—Memantine—Alzheimer's disease	0.00111	0.00877	CcSEcCtD
Phentolamine—Chest pain—Memantine—Alzheimer's disease	0.0011	0.00865	CcSEcCtD
Phentolamine—Hypertension—Rivastigmine—Alzheimer's disease	0.00109	0.00858	CcSEcCtD
Phentolamine—Hypotension—Donepezil—Alzheimer's disease	0.00108	0.00853	CcSEcCtD
Phentolamine—ADRA1A—forebrain—Alzheimer's disease	0.00107	0.0412	CbGeAlD
Phentolamine—Chest pain—Rivastigmine—Alzheimer's disease	0.00107	0.00846	CcSEcCtD
Phentolamine—Asthenia—Galantamine—Alzheimer's disease	0.00107	0.00846	CcSEcCtD
Phentolamine—Paraesthesia—Donepezil—Alzheimer's disease	0.00104	0.0082	CcSEcCtD
Phentolamine—ADRA1B—nervous system—Alzheimer's disease	0.00104	0.0398	CbGeAlD
Phentolamine—Nervous system disorder—Memantine—Alzheimer's disease	0.00103	0.00813	CcSEcCtD
Phentolamine—Tachycardia—Memantine—Alzheimer's disease	0.00103	0.00809	CcSEcCtD
Phentolamine—Diarrhoea—Galantamine—Alzheimer's disease	0.00102	0.00806	CcSEcCtD
Phentolamine—ADRA1D—nervous system—Alzheimer's disease	0.00101	0.0389	CbGeAlD
Phentolamine—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.00101	0.00796	CcSEcCtD
Phentolamine—Tachycardia—Rivastigmine—Alzheimer's disease	0.001	0.00792	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000999	0.00788	CcSEcCtD
Phentolamine—ADRA1B—central nervous system—Alzheimer's disease	0.000998	0.0383	CbGeAlD
Phentolamine—Pain—Donepezil—Alzheimer's disease	0.000989	0.00781	CcSEcCtD
Phentolamine—Dizziness—Galantamine—Alzheimer's disease	0.000987	0.00779	CcSEcCtD
Phentolamine—ADRA1A—telencephalon—Alzheimer's disease	0.000987	0.0378	CbGeAlD
Phentolamine—Hypotension—Memantine—Alzheimer's disease	0.000982	0.00775	CcSEcCtD
Phentolamine—ADRA1D—central nervous system—Alzheimer's disease	0.000977	0.0375	CbGeAlD
Phentolamine—Hypotension—Rivastigmine—Alzheimer's disease	0.00096	0.00758	CcSEcCtD
Phentolamine—Vomiting—Galantamine—Alzheimer's disease	0.000949	0.00749	CcSEcCtD
Phentolamine—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000946	0.00747	CcSEcCtD
Phentolamine—Paraesthesia—Memantine—Alzheimer's disease	0.000943	0.00745	CcSEcCtD
Phentolamine—ADRA2C—telencephalon—Alzheimer's disease	0.00094	0.0361	CbGeAlD
Phentolamine—Headache—Galantamine—Alzheimer's disease	0.000935	0.00738	CcSEcCtD
Phentolamine—NISCH—brain—Alzheimer's disease	0.000929	0.0356	CbGeAlD
Phentolamine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000923	0.00728	CcSEcCtD
Phentolamine—Abdominal pain—Donepezil—Alzheimer's disease	0.000915	0.00722	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000907	0.00716	CcSEcCtD
Phentolamine—Pain—Memantine—Alzheimer's disease	0.000898	0.00709	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000887	0.007	CcSEcCtD
Phentolamine—Nausea—Galantamine—Alzheimer's disease	0.000887	0.007	CcSEcCtD
Phentolamine—Pain—Rivastigmine—Alzheimer's disease	0.000879	0.00694	CcSEcCtD
Phentolamine—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000859	0.00678	CcSEcCtD
Phentolamine—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.00084	0.00663	CcSEcCtD
Phentolamine—Abdominal pain—Memantine—Alzheimer's disease	0.00083	0.00656	CcSEcCtD
Phentolamine—Asthenia—Donepezil—Alzheimer's disease	0.00083	0.00655	CcSEcCtD
Phentolamine—Pruritus—Donepezil—Alzheimer's disease	0.000819	0.00646	CcSEcCtD
Phentolamine—ADRA2A—forebrain—Alzheimer's disease	0.000816	0.0313	CbGeAlD
Phentolamine—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000812	0.00641	CcSEcCtD
Phentolamine—ADRA1B—brain—Alzheimer's disease	0.000793	0.0304	CbGeAlD
Phentolamine—Diarrhoea—Donepezil—Alzheimer's disease	0.000792	0.00625	CcSEcCtD
Phentolamine—ADRA1D—brain—Alzheimer's disease	0.000775	0.0297	CbGeAlD
Phentolamine—Dizziness—Donepezil—Alzheimer's disease	0.000765	0.00604	CcSEcCtD
Phentolamine—Asthenia—Memantine—Alzheimer's disease	0.000754	0.00595	CcSEcCtD
Phentolamine—ADRA2A—telencephalon—Alzheimer's disease	0.00075	0.0288	CbGeAlD
Phentolamine—Pruritus—Memantine—Alzheimer's disease	0.000743	0.00587	CcSEcCtD
Phentolamine—Asthenia—Rivastigmine—Alzheimer's disease	0.000737	0.00582	CcSEcCtD
Phentolamine—Vomiting—Donepezil—Alzheimer's disease	0.000736	0.00581	CcSEcCtD
Phentolamine—Pruritus—Rivastigmine—Alzheimer's disease	0.000727	0.00574	CcSEcCtD
Phentolamine—Headache—Donepezil—Alzheimer's disease	0.000725	0.00572	CcSEcCtD
Phentolamine—Diarrhoea—Memantine—Alzheimer's disease	0.000719	0.00567	CcSEcCtD
Phentolamine—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000703	0.00555	CcSEcCtD
Phentolamine—Dizziness—Memantine—Alzheimer's disease	0.000695	0.00548	CcSEcCtD
Phentolamine—Nausea—Donepezil—Alzheimer's disease	0.000687	0.00542	CcSEcCtD
Phentolamine—Dizziness—Rivastigmine—Alzheimer's disease	0.00068	0.00536	CcSEcCtD
Phentolamine—Vomiting—Memantine—Alzheimer's disease	0.000668	0.00527	CcSEcCtD
Phentolamine—SIGMAR1—cerebellum—Alzheimer's disease	0.000665	0.0255	CbGeAlD
Phentolamine—Headache—Memantine—Alzheimer's disease	0.000658	0.00519	CcSEcCtD
Phentolamine—Vomiting—Rivastigmine—Alzheimer's disease	0.000653	0.00516	CcSEcCtD
Phentolamine—Headache—Rivastigmine—Alzheimer's disease	0.000644	0.00508	CcSEcCtD
Phentolamine—Nausea—Memantine—Alzheimer's disease	0.000624	0.00493	CcSEcCtD
Phentolamine—Nausea—Rivastigmine—Alzheimer's disease	0.00061	0.00482	CcSEcCtD
Phentolamine—ADRA1A—nervous system—Alzheimer's disease	0.000583	0.0223	CbGeAlD
Phentolamine—ADRA1A—central nervous system—Alzheimer's disease	0.000561	0.0215	CbGeAlD
Phentolamine—ADRA2C—nervous system—Alzheimer's disease	0.000555	0.0213	CbGeAlD
Phentolamine—ADRA1A—cerebellum—Alzheimer's disease	0.000548	0.021	CbGeAlD
Phentolamine—SIGMAR1—brain—Alzheimer's disease	0.00054	0.0207	CbGeAlD
Phentolamine—ADRA2C—central nervous system—Alzheimer's disease	0.000535	0.0205	CbGeAlD
Phentolamine—ADRA2C—cerebellum—Alzheimer's disease	0.000522	0.02	CbGeAlD
Phentolamine—ADRA1A—brain—Alzheimer's disease	0.000445	0.0171	CbGeAlD
Phentolamine—ADRA2A—nervous system—Alzheimer's disease	0.000443	0.017	CbGeAlD
Phentolamine—ADRA2A—central nervous system—Alzheimer's disease	0.000427	0.0164	CbGeAlD
Phentolamine—ADRA2C—brain—Alzheimer's disease	0.000424	0.0163	CbGeAlD
Phentolamine—ADRA2A—cerebellum—Alzheimer's disease	0.000417	0.016	CbGeAlD
Phentolamine—ADRA2A—brain—Alzheimer's disease	0.000339	0.013	CbGeAlD
Phentolamine—ADRA2C—Hemostasis—TGFB1—Alzheimer's disease	1.77e-05	0.000235	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—CREB1—Alzheimer's disease	1.76e-05	0.000233	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—APP—Alzheimer's disease	1.76e-05	0.000233	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—NPS—Alzheimer's disease	1.76e-05	0.000233	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—S100B—Alzheimer's disease	1.75e-05	0.000232	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—PPP3CA—Alzheimer's disease	1.75e-05	0.000232	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—NGFR—Alzheimer's disease	1.74e-05	0.000231	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—CREB1—Alzheimer's disease	1.73e-05	0.00023	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—ADAM10—Alzheimer's disease	1.73e-05	0.000229	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—F2—Alzheimer's disease	1.73e-05	0.000229	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—LPL—Alzheimer's disease	1.73e-05	0.000229	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—PTK2B—Alzheimer's disease	1.72e-05	0.000229	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—CCL2—Alzheimer's disease	1.72e-05	0.000228	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—LPL—Alzheimer's disease	1.71e-05	0.000227	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—ADAM10—Alzheimer's disease	1.7e-05	0.000226	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—MEF2C—Alzheimer's disease	1.7e-05	0.000225	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—CCL2—Alzheimer's disease	1.7e-05	0.000225	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—F2—Alzheimer's disease	1.69e-05	0.000224	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—NTRK2—Alzheimer's disease	1.68e-05	0.000222	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—SST—Alzheimer's disease	1.68e-05	0.000222	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—GAB2—Alzheimer's disease	1.68e-05	0.000222	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—CALM1—Alzheimer's disease	1.67e-05	0.000222	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—IGF2—Alzheimer's disease	1.67e-05	0.000221	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—PRKCG—Alzheimer's disease	1.66e-05	0.000221	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—GSK3A—Alzheimer's disease	1.66e-05	0.00022	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—PLCB1—Alzheimer's disease	1.66e-05	0.00022	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—S100B—Alzheimer's disease	1.64e-05	0.000217	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—APP—Alzheimer's disease	1.63e-05	0.000217	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—NGF—Alzheimer's disease	1.62e-05	0.000215	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—IGF1R—Alzheimer's disease	1.61e-05	0.000214	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—S100B—Alzheimer's disease	1.61e-05	0.000214	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CCR5—Alzheimer's disease	1.58e-05	0.000209	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—F2—Alzheimer's disease	1.57e-05	0.000208	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—VEGFA—Alzheimer's disease	1.57e-05	0.000208	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—TP53—Alzheimer's disease	1.56e-05	0.000207	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—IGF2—Alzheimer's disease	1.56e-05	0.000207	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—MTHFR—Alzheimer's disease	1.55e-05	0.000206	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—NGFR—Alzheimer's disease	1.55e-05	0.000205	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—LPL—Alzheimer's disease	1.55e-05	0.000205	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—HTR2A—Alzheimer's disease	1.54e-05	0.000205	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—PLCB1—Alzheimer's disease	1.54e-05	0.000205	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—PPARGC1A—Alzheimer's disease	1.54e-05	0.000204	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—CREB1—Alzheimer's disease	1.54e-05	0.000204	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—HMOX1—Alzheimer's disease	1.53e-05	0.000203	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—IGF2—Alzheimer's disease	1.53e-05	0.000203	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—MEF2C—Alzheimer's disease	1.53e-05	0.000203	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—ADAM10—Alzheimer's disease	1.51e-05	0.000201	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—IGF1R—Alzheimer's disease	1.51e-05	0.0002	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—CCL2—Alzheimer's disease	1.51e-05	0.0002	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—PRKCG—Alzheimer's disease	1.5e-05	0.000199	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—IGF1R—Alzheimer's disease	1.48e-05	0.000197	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—NGF—Alzheimer's disease	1.46e-05	0.000194	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—TP53—Alzheimer's disease	1.46e-05	0.000193	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—CALM1—Alzheimer's disease	1.45e-05	0.000193	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—APOE—Alzheimer's disease	1.45e-05	0.000192	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—LPL—Alzheimer's disease	1.44e-05	0.000192	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CALM1—Alzheimer's disease	1.44e-05	0.000191	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—NGFR—Alzheimer's disease	1.44e-05	0.000191	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—TGFB1—Alzheimer's disease	1.44e-05	0.000191	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—LEP—Alzheimer's disease	1.44e-05	0.00019	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—APOE—Alzheimer's disease	1.44e-05	0.00019	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—CAV1—Alzheimer's disease	1.43e-05	0.00019	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—MEF2C—Alzheimer's disease	1.43e-05	0.00019	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—S100B—Alzheimer's disease	1.43e-05	0.00019	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—CREB1—Alzheimer's disease	1.43e-05	0.00019	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CCR5—Alzheimer's disease	1.42e-05	0.000189	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CAV1—Alzheimer's disease	1.42e-05	0.000189	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—LPL—Alzheimer's disease	1.42e-05	0.000188	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—MEF2C—Alzheimer's disease	1.41e-05	0.000187	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—ADAM10—Alzheimer's disease	1.41e-05	0.000186	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—PRKCG—Alzheimer's disease	1.4e-05	0.000186	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—LPL—Alzheimer's disease	1.4e-05	0.000186	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—CCL2—Alzheimer's disease	1.4e-05	0.000186	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—HTR2A—Alzheimer's disease	1.39e-05	0.000185	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—PRKCG—Alzheimer's disease	1.38e-05	0.000183	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—ESR1—Alzheimer's disease	1.37e-05	0.000182	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—NGF—Alzheimer's disease	1.37e-05	0.000181	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—IGF2—Alzheimer's disease	1.36e-05	0.000181	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—F2—Alzheimer's disease	1.35e-05	0.00018	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—NGF—Alzheimer's disease	1.35e-05	0.000179	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CCR5—Alzheimer's disease	1.33e-05	0.000176	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—S100B—Alzheimer's disease	1.33e-05	0.000176	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—NOTCH1—Alzheimer's disease	1.32e-05	0.000176	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—IGF1R—Alzheimer's disease	1.32e-05	0.000175	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—AKT1—Alzheimer's disease	1.32e-05	0.000175	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CCR5—Alzheimer's disease	1.31e-05	0.000174	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—HTR2A—Alzheimer's disease	1.3e-05	0.000173	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CALM1—Alzheimer's disease	1.3e-05	0.000172	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—APOE—Alzheimer's disease	1.3e-05	0.000172	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—LEP—Alzheimer's disease	1.3e-05	0.000172	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CAV1—Alzheimer's disease	1.28e-05	0.00017	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—HTR2A—Alzheimer's disease	1.28e-05	0.00017	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—IGF2—Alzheimer's disease	1.27e-05	0.000168	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—MTHFR—Alzheimer's disease	1.26e-05	0.000168	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—LPL—Alzheimer's disease	1.26e-05	0.000167	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—PPARG—Alzheimer's disease	1.26e-05	0.000167	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—MEF2C—Alzheimer's disease	1.25e-05	0.000166	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—GSK3B—Alzheimer's disease	1.24e-05	0.000165	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—ESR1—Alzheimer's disease	1.24e-05	0.000164	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—INS—Alzheimer's disease	1.24e-05	0.000164	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CREB1—Alzheimer's disease	1.23e-05	0.000164	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—AKT1—Alzheimer's disease	1.23e-05	0.000163	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—PRKCG—Alzheimer's disease	1.23e-05	0.000163	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—INS—Alzheimer's disease	1.23e-05	0.000163	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—IGF1R—Alzheimer's disease	1.22e-05	0.000162	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—F2—Alzheimer's disease	1.22e-05	0.000162	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CALM1—Alzheimer's disease	1.21e-05	0.000161	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—LEP—Alzheimer's disease	1.21e-05	0.000161	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—APOE—Alzheimer's disease	1.21e-05	0.000161	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CCL2—Alzheimer's disease	1.21e-05	0.00016	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CAV1—Alzheimer's disease	1.2e-05	0.000159	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—NOTCH1—Alzheimer's disease	1.2e-05	0.000159	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—NGF—Alzheimer's disease	1.2e-05	0.000159	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CALM1—Alzheimer's disease	1.2e-05	0.000159	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—LEP—Alzheimer's disease	1.19e-05	0.000158	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—APOE—Alzheimer's disease	1.19e-05	0.000158	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—IGF1—Alzheimer's disease	1.19e-05	0.000157	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—TP53—Alzheimer's disease	1.18e-05	0.000157	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CAV1—Alzheimer's disease	1.18e-05	0.000157	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—CALM1—Alzheimer's disease	1.18e-05	0.000156	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—APOE—Alzheimer's disease	1.18e-05	0.000156	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—LPL—Alzheimer's disease	1.17e-05	0.000156	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—CAV1—Alzheimer's disease	1.16e-05	0.000155	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CCR5—Alzheimer's disease	1.16e-05	0.000154	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—MEF2C—Alzheimer's disease	1.16e-05	0.000154	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—ESR1—Alzheimer's disease	1.16e-05	0.000153	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—F2—Alzheimer's disease	1.14e-05	0.000151	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—PRKCG—Alzheimer's disease	1.14e-05	0.000151	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—HTR2A—Alzheimer's disease	1.14e-05	0.000151	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—ESR1—Alzheimer's disease	1.14e-05	0.000151	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—F2—Alzheimer's disease	1.12e-05	0.000149	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—GSK3B—Alzheimer's disease	1.12e-05	0.000149	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—NOTCH1—Alzheimer's disease	1.12e-05	0.000148	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CREB1—Alzheimer's disease	1.11e-05	0.000148	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—NGF—Alzheimer's disease	1.11e-05	0.000147	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—INS—Alzheimer's disease	1.11e-05	0.000147	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—NOTCH1—Alzheimer's disease	1.1e-05	0.000146	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CCL2—Alzheimer's disease	1.09e-05	0.000144	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—NOS3—Alzheimer's disease	1.08e-05	0.000144	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CCR5—Alzheimer's disease	1.08e-05	0.000143	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—NOS3—Alzheimer's disease	1.08e-05	0.000143	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—IGF1—Alzheimer's disease	1.07e-05	0.000142	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CALM1—Alzheimer's disease	1.06e-05	0.000141	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—LEP—Alzheimer's disease	1.06e-05	0.00014	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—APOE—Alzheimer's disease	1.06e-05	0.00014	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—HTR2A—Alzheimer's disease	1.06e-05	0.00014	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CAV1—Alzheimer's disease	1.05e-05	0.000139	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—GSK3B—Alzheimer's disease	1.05e-05	0.000139	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CREB1—Alzheimer's disease	1.04e-05	0.000138	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—INS—Alzheimer's disease	1.03e-05	0.000137	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—GSK3B—Alzheimer's disease	1.03e-05	0.000137	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—PPARG—Alzheimer's disease	1.02e-05	0.000136	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CREB1—Alzheimer's disease	1.02e-05	0.000136	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—INS—Alzheimer's disease	1.02e-05	0.000135	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CCL2—Alzheimer's disease	1.02e-05	0.000135	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—ESR1—Alzheimer's disease	1.01e-05	0.000134	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—INS—Alzheimer's disease	1e-05	0.000133	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CCL2—Alzheimer's disease	1e-05	0.000133	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—IGF1—Alzheimer's disease	1e-05	0.000133	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—AKT1—Alzheimer's disease	9.99e-06	0.000132	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—F2—Alzheimer's disease	9.98e-06	0.000132	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—PTGS2—Alzheimer's disease	9.92e-06	0.000132	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CALM1—Alzheimer's disease	9.87e-06	0.000131	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—IGF1—Alzheimer's disease	9.84e-06	0.000131	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—LEP—Alzheimer's disease	9.83e-06	0.00013	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—APOE—Alzheimer's disease	9.83e-06	0.00013	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—NOTCH1—Alzheimer's disease	9.77e-06	0.00013	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CAV1—Alzheimer's disease	9.74e-06	0.000129	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—NOS3—Alzheimer's disease	9.71e-06	0.000129	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—ESR1—Alzheimer's disease	9.39e-06	0.000124	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—F2—Alzheimer's disease	9.27e-06	0.000123	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—AKT1—Alzheimer's disease	9.21e-06	0.000122	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—GSK3B—Alzheimer's disease	9.16e-06	0.000122	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CASP3—Alzheimer's disease	9.13e-06	0.000121	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CREB1—Alzheimer's disease	9.09e-06	0.000121	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—NOTCH1—Alzheimer's disease	9.07e-06	0.00012	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—IL6—Alzheimer's disease	9.07e-06	0.00012	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—NOS3—Alzheimer's disease	9.07e-06	0.00012	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—INS—Alzheimer's disease	9.04e-06	0.00012	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—NOS3—Alzheimer's disease	8.92e-06	0.000118	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CCL2—Alzheimer's disease	8.89e-06	0.000118	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—NOS3—Alzheimer's disease	8.81e-06	0.000117	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—IGF1—Alzheimer's disease	8.74e-06	0.000116	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—GSK3B—Alzheimer's disease	8.51e-06	0.000113	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CREB1—Alzheimer's disease	8.45e-06	0.000112	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—INS—Alzheimer's disease	8.4e-06	0.000111	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—MAPK8—Alzheimer's disease	8.39e-06	0.000111	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—AKT1—Alzheimer's disease	8.37e-06	0.000111	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—AKT1—Alzheimer's disease	8.32e-06	0.00011	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CCL2—Alzheimer's disease	8.26e-06	0.00011	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CASP3—Alzheimer's disease	8.24e-06	0.000109	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—IL6—Alzheimer's disease	8.19e-06	0.000109	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—IGF1—Alzheimer's disease	8.12e-06	0.000108	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—PTGS2—Alzheimer's disease	8.06e-06	0.000107	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—NOS3—Alzheimer's disease	7.93e-06	0.000105	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—AKT1—Alzheimer's disease	7.77e-06	0.000103	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—VEGFA—Alzheimer's disease	7.75e-06	0.000103	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CASP3—Alzheimer's disease	7.7e-06	0.000102	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—IL6—Alzheimer's disease	7.65e-06	0.000101	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—AKT1—Alzheimer's disease	7.65e-06	0.000101	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CASP3—Alzheimer's disease	7.58e-06	0.0001	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—MAPK8—Alzheimer's disease	7.57e-06	0.0001	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—AKT1—Alzheimer's disease	7.55e-06	0.0001	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—IL6—Alzheimer's disease	7.53e-06	9.98e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—NOS3—Alzheimer's disease	7.37e-06	9.77e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—TGFB1—Alzheimer's disease	7.11e-06	9.43e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—MAPK8—Alzheimer's disease	7.08e-06	9.38e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—AKT1—Alzheimer's disease	7.06e-06	9.36e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—VEGFA—Alzheimer's disease	6.99e-06	9.28e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—MAPK8—Alzheimer's disease	6.96e-06	9.24e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—AKT1—Alzheimer's disease	6.94e-06	9.21e-05	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—AKT1—Alzheimer's disease	6.79e-06	9.01e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CASP3—Alzheimer's disease	6.73e-06	8.93e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—IL6—Alzheimer's disease	6.69e-06	8.87e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—VEGFA—Alzheimer's disease	6.53e-06	8.66e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—VEGFA—Alzheimer's disease	6.43e-06	8.53e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—TGFB1—Alzheimer's disease	6.42e-06	8.51e-05	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—AKT1—Alzheimer's disease	6.31e-06	8.37e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CASP3—Alzheimer's disease	6.25e-06	8.29e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—IL6—Alzheimer's disease	6.21e-06	8.24e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—MAPK8—Alzheimer's disease	6.19e-06	8.2e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—AKT1—Alzheimer's disease	6.17e-06	8.18e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—TGFB1—Alzheimer's disease	6e-06	7.95e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—TGFB1—Alzheimer's disease	5.9e-06	7.83e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—TP53—Alzheimer's disease	5.85e-06	7.76e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—MAPK8—Alzheimer's disease	5.75e-06	7.62e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—AKT1—Alzheimer's disease	5.73e-06	7.6e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—VEGFA—Alzheimer's disease	5.71e-06	7.57e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—IL6—Alzheimer's disease	5.36e-06	7.11e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—VEGFA—Alzheimer's disease	5.31e-06	7.04e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—TP53—Alzheimer's disease	5.28e-06	7.01e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—TGFB1—Alzheimer's disease	5.24e-06	6.95e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—AKT1—Alzheimer's disease	4.99e-06	6.61e-05	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—AKT1—Alzheimer's disease	4.94e-06	6.56e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—TP53—Alzheimer's disease	4.94e-06	6.55e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—TGFB1—Alzheimer's disease	4.87e-06	6.46e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—TP53—Alzheimer's disease	4.86e-06	6.44e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—IL6—Alzheimer's disease	4.84e-06	6.42e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—IL6—Alzheimer's disease	4.52e-06	5.99e-05	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—AKT1—Alzheimer's disease	4.46e-06	5.92e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—IL6—Alzheimer's disease	4.45e-06	5.9e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—TP53—Alzheimer's disease	4.32e-06	5.72e-05	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—AKT1—Alzheimer's disease	4.17e-06	5.53e-05	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—AKT1—Alzheimer's disease	4.1e-06	5.44e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—AKT1—Alzheimer's disease	4.05e-06	5.37e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—TP53—Alzheimer's disease	4.01e-06	5.32e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—IL6—Alzheimer's disease	3.95e-06	5.24e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—IL6—Alzheimer's disease	3.67e-06	4.87e-05	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—AKT1—Alzheimer's disease	3.64e-06	4.83e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—AKT1—Alzheimer's disease	3.39e-06	4.49e-05	CbGpPWpGaD
